p120-Catenin Down-Regulation and Epidermal Growth Factor Receptor Overexpression Results in a Transformed Epithelium That Mimics Esophageal Squamous Cell Carcinoma  by Lehman, Heather L. et al.
The American Journal of Pathology, Vol. 185, No. 1, January 2015TUMORIGENESIS AND NEOPLASTIC PROGRESSION
ajp.amjpathol.orgp120-Catenin Down-Regulation and Epidermal
Growth Factor Receptor Overexpression Results
in a Transformed Epithelium That Mimics
Esophageal Squamous Cell Carcinoma
Heather L. Lehman, Xuebin Yang, Patricia A. Welsh, and Douglas B. StairsFrom the Department of Pathology, The Pennsylvania State University College of Medicine, Hershey, PennsylvaniaAccepted for publicationC
P
hSeptember 2, 2014.
Address correspondence to
Douglas B. Stairs, Ph.D.,
Department of Pathology, The
Pennsylvania State University
College of Medicine, 500 Uni-
versity Dr, Mail Code H083,
Hershey, PA 17033. E-mail:
dbs18@psu.edu.opyright ª 2015 American Society for Inve
ublished by Elsevier Inc. All rights reserved
ttp://dx.doi.org/10.1016/j.ajpath.2014.09.008Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with a poor prognosis due to
its highly invasive and metastatic potential. The molecular pathogenesis underlying the invasive
mechanism of ESCC is not well known because of the lack of existing models to study this disease. p120-
Catenin (p120ctn) and the epidermal growth factor receptor (EGFR) have each been implicated in
several cancers, including ESCC. p120ctn is down-regulated in 60% of ESCC tumors, whereas EGFR is the
most commonly overexpressed oncogene in ESCC. For these reasons, we investigated the cooperation
between p120ctn and EGFR and its effect on ESCC invasion. We show that p120ctn down-regulation is
commonly associated with EGFR overexpression. By using a three-dimensional culture system, we
demonstrate that the inverse relationship between p120ctn and EGFR has biological implications.
Speciﬁcally, p120ctn down-regulation coupled with EGFR overexpression in human esophageal kerati-
nocytes (EPC1-PE) was required to promote invasion. Morphological comparison of EPC1-PE cells grown
in three-dimensional culture and human ESCC revealed identical features, including signiﬁcantly
increased cellularity, nuclear grade, and proliferation. Molecular characteristics were measured by
keratin expression patterns, which were nearly identical between EPC1-PE cells in three-dimensional
culture and ESCC samples. Altogether, our analyses have demonstrated that p120ctn down-regulation
and EGFR overexpression are able to mimic human ESCC in a relevant three-dimensional culture model.
(Am J Pathol 2015, 185: 240e251; http://dx.doi.org/10.1016/j.ajpath.2014.09.008)Supported by the Pennsylvania Department of Health using Tobacco
CURE funds (D.S.), NIH grant R00CA138498 (D.S.), and the Penn State
College of Medicine Department of Pathology Research Award Program
(X.Y. and D.S.).
Disclosures: None declared.Esophageal cancer is the eighth most common cancer type1 in
the United States, ranking as the seventh leading cause of
cancer-related mortality in the United States2 and ﬁfth
worldwide.3 Esophageal cancers are classiﬁed into two
distinct histological subtypes with unique clinical behaviors:
esophageal squamous cell carcinoma (ESCC) and esopha-
geal adenocarcinoma. ESCC is a highly aggressive malig-
nancy that is typically diagnosed at an advanced tumor
stage.3e5 The disease develops as the result of a multistep
process, arising as squamous dysplasia in the stratiﬁed
squamous epithelium of the esophageal mucosa and subse-
quently invading through the submucosa and muscle layers
of the esophagus.6 ESCC is aggressive, with a high rate of
direct local invasion to adjacent organs, such as the aorta,
respiratory tract, and lungs.7 The underlying molecularstigative Pathology.
.pathogenesis and biological features of this invasive mech-
anism in ESCC are not known and are understudied because
of the lack of existing models available.
p120-Catenin (p120ctn; alias CTNND1) is a tumor sup-
pressor gene whose down-regulation is correlated with
poorly differentiated tumors and a metastatic phenotype in
several cancers, including prostate, lung, and adenocarci-
noma of the gastroesophageal junction.8e10 It has been
shown previously that p120ctn is either down-regulated or
lost in 35% to 60% of ESCC tumors.11,12 Epidermal growth
p120ctn and EGFR Mimic ESCC in 3D Modelfactor receptor (EGFR) is the most commonly overex-
pressed oncogene in many cancer types, including ESCC,13
with the ability to modulate signal transduction pathways
involved in tumor cell migration, proliferation, angiogen-
esis, and inhibition of apoptosis.14,15 EGFR is overex-
pressed in 43% to 97% of ESCC patients,15e18 and its
overexpression is signiﬁcantly correlated with the depth of
tumor invasion.15
Because p120ctn is so often down-regulated or lost and
EGFR is so often overexpressed in ESCC, we focused on
investigating the cooperation between these pathways in ESCC.
In addition, we used a novel and relevant three-dimensional
(3D) tissue culture model using immortalized human esopha-
geal keratinocytes (EPC1-hTERT) grown to form an epithelium
on an extracellular matrix embedded with human esophageal
ﬁbroblasts19 with which to study the disease.
This model constitutes a complete stratiﬁed squamous
epithelium, histologically resembles in vivo esophageal
epithelium, and recreates the normal differentiation program
of the esophagus.19e21 We assessed the intersection of two
genetic events (namely, down-regulation of the tumor sup-
pressor p120ctn and overexpression of the oncogene EGFR),
and its ability to lead to an invasive ESCC phenotype. Our
data suggest that p120ctn down-regulation and EGFR over-
expression in our 3D model are able to mimic human ESCC.
Materials and Methods
Cell Lines
EPC1-hTERT and EPC2-hTERT cells were a gracious gift
from Anil K. Rustgi (University of Pennsylvania, Philadel-
phia, PA).20 EPC1-hTERT and EPC2-hTERT cells were
grown in keratinocyte serum-free medium (Invitrogen,
Carlsbad, CA) supplemented with 40 mg/mL bovine pituitary
extract (Invitrogen), 1.0 ng/mL EGF (Invitrogen), 100 U/mL
penicillin, and 100 mg/mL streptomycin (Invitrogen) and
maintained at 37C and 5% CO2. Modiﬁcations of EPC1-
hTERT and EPC2-hTERT cells were made with TRIPZ
(Open Biosystems, Waltham, MA) and pLVX (Clontech,
Mountain View, CA) vectors. All derivatives of parental
EPC1-hTERT and EPC2-hTERT cells will be termed EPC1-
(genetic modiﬁcation) or EPC2-(genetic modiﬁcation),
respectively. EPC1-hTERT cells with down-regulation of
p120ctn (EPC1-P cells) were generated by infection of
EPC1-hTERT cells with a TRIPZ inducible lentiviral
p120ctn shRNA purchased from Open Biosystems
(V2THS_113295). Down-regulation of p120ctn was induced
through 1 mg/mL doxycycline treatment of cells for 72 hours.
The pLVX-IRES-Neo vector purchased from Clontech was
used to express EGFRdel (E746-A750). EPC1-hTERT cells
with overexpression of EGFR (EPC1-E cells) were generated
by infection of EPC1-hTERT cells with a pLVX-IRES-Neo-
EGFRdel (E746-A750) vector. EPC1-hTERT cells with
down-regulated p120ctn and overexpressed EGFR (EPC1-
PE cells) were generated by infection of EPC1-hTERTThe American Journal of Pathology - ajp.amjpathol.orgcells with both a TRIPZ inducible lentiviral p120ctn shRNA
and a pLVX-IRES-Neo-EGFRdel (746-750) vector. EPC2-
hTERT cells were modiﬁed in an identical manner as
described for EPC1-hTERT cells to generate EPC2-P, EPC2-E,
and EPC2-PE cells. Activated human fetal esophageal ﬁbro-
blasts (FEF3) and quiescent human adult esophageal ﬁbroblasts
(HEFs) were gracious gifts from Anil K. Rustgi20 and were
grown in Dulbecco’s modiﬁed Eagle’s medium (Mediatech,
Inc., Manassas, VA) supplemented with 10% fetal bovine
serum (HyClone; Thermo Scientiﬁc, Waltham, MA), 100 U/
mL penicillin, and 100 mg/mL streptomycin (Invitrogen).
Western Blot Analysis
EPC1-hTERT cells were harvested and incubated in lysis buffer
[1% Triton X-100, 1% Nonidet P-40, 150 mmol/L NaCl, 50
mmol/L Tris (pH 8.0), and protease inhibitors (Roche, Indian-
apolis, IN) and phosphatase inhibitors (10mmol/L Na, 2 mmol/
L Na3VO4, and 5 mmol/L Na-pyrophosphate)]. Denatured
proteins were resolved by SDS-PAGE and transferred to a
polyvinylidene diﬂuoride membrane (Immobilon-P; Millipore,
Billerica, MA). Membranes were incubated overnight at 4C
with primary antibodies, followed by appropriate horseradish
peroxidase (HRP)econjugated secondary antibodies for 1 hour
at room temperature. Proteins were visualized using ECL
Prime chemiluminescence (GE Healthcare, Piscataway, NJ),
according to the manufacturer’s instructions.
Migration and Invasion Assays
Migration assays were performed using Boyden transwell
chambers with 8-mm pore ﬁlters (BD Biosciences, San Jose,
CA). Invasion assays were performed using BD Biocoat
Matrigel Invasion Chambers with 8-mm pore ﬁlters (BD
Biosciences). For both assays, the bottom wells of the com-
panion plate were ﬁlled with serum-containing medium to act
as a chemoattractant for the cells. Cells (2.5  104) were
seeded in keratinocyte serum-free medium in each insert.
Migration assays were incubated for 8 hours and invasion
assays were incubated for 12 hours at 37C in a humidiﬁed
incubator with 5% CO2. Migratory and invasive cells were
stained with a Diff-Quick stain set (Fisher Scientiﬁc,Waltham,
MA).Migrated or invaded cells were imagedwith anOlympus
BX53 light microscope (Olympus America, Center Valley,
PA) and counted in ﬁve random ﬁelds.
3D Organotypic Culture
EPC1-hTERT human esophageal keratinocytes were grown
in organotypic culture on a 3D matrix, as previously
described.19 An acellular collagen layer was applied to a
transwell insert, followed by a collagen/Matrigel layer with
7.5  104 human fetal or adult esophageal ﬁbroblasts.
Matrices were allowed to contract for 7 days, at which point
5  105 epithelial cells were seeded on top of the matrix.
Cultures were grown for an additional 8 days and then241
Figure 1 p120ctn Down-regulation and epidermal growth factor receptor (EGFR) overexpression in human ESCC. A: H&E staining of human normal
esophageal epithelium. B: p120ctn Expression in normal esophageal epithelium. C: EGFR expression in normal esophageal epithelium. D: H&E staining of
human esophageal squamous cell carcinoma (ESCC). E: p120ctn Expression is decreased in human ESCC tissue. F: EGFR expression is decreased in human ESCC
tissue. Insets (B, C, E, and F): Protein localization at a higher magniﬁcation. Scale bar Z 100 mm.
Table 1 Down-Regulation of p120ctn with Overexpression of
EGFR Is Overrepresented in ESCC Human Samples
Variable
p120ctn Decrease
(H-score Z 158)
p120ctn No
change/increase
(H-score Z 226)
EGFR no change/decrease
(H-score Z 138)
1/24 (4) 3/24 (12)
EGFR increase
(H-score Z 250)
16/24 (67) 4/24 (17)
Data are given as number/total (percentage).
Lehman et alharvested. Half of the culture was ﬁxed in 10% neutral-
buffered formalin (Fisher Scientiﬁc) and parafﬁn
embedded, whereas epithelium was peeled from the top of
the other half of the culture and lysed for protein.
Patients and Specimens
Approval was obtained from the Institutional Review Board of
Pennsylvania State Hershey Medical Center for all human
sample experiments performed in this study. The Surgical
Pathology Archive of the Pennsylvania State HersheyMedical
Center was searched for ESCC cases. A total of 24 parafﬁn-
embedded human ESCC cases with normal-appearing adja-
cent epithelium between 1978 and 2013 were selected for
inclusion in this study. A hematoxylin and eosin (H&E)e
stained section of each case was examined by an anatomical
pathologist (X.Y.) to conﬁrm the diagnosis. All of the selected
ESCC cases were moderately well differentiated. Half of the
specimens were resections, and the other half were biopsy
specimens. Staging information was unavailable for biopsy
patients. The 12 surgical resection specimens varied in size
and stage, although no specimens were stage IV. Ten human
normal esophageal epithelium samples used as controls were
also selected for inclusion in this study. Handling of tissue
specimens and protection of patient privacy followed strict
policies of the Institutional Review Board.
IHC Data
Formalin-ﬁxed, parafﬁn-embedded sections were divided into
sections (5 mm thick). Tissue sections were baked for 1 hour at24260C and deparafﬁnized in xylene. Immunohistochemistry
(IHC) on human tissues was performed by The Pennsylvania
State University College of Medicine (Hershey, PA)
Morphological and Molecular Pathology Core Research Lab
on a Dako Autostainer Plus (Dako Cytomation, Carpinteria,
CA). For 3D organotypic culture sections, antigen unmasking
was performed with the Retriever (Electron Microscopy Sci-
ences, Hatﬁeld, PA) in either 10mmol/L sodium citrate buffer,
pH 6.0, or EDTA buffer, pH 8.0. Endogenous peroxidase
activity was blocked by incubation with 3% hydrogen
peroxide for 6 minutes. Sections were incubated with primary
antibodies overnight at 4C, followed by 30 minutes with the
appropriate ImmPRESS reagent, either HRP anti-mouse Ig or
HRP anti-rabbit Ig (Vector Laboratories, Burlingame, CA),
according to the manufacturer’s protocol. HRP activity was
then detected using diaminobenzidene substrate (Thermo
Scientiﬁc) for 10 minutes before coverslipping with Permount
(Fisher Scientiﬁc). The sections were evaluated on an
Olympus BX53 light microscope at 100, 200, and 400ajp.amjpathol.org - The American Journal of Pathology
p120ctn and EGFR Mimic ESCC in 3D Modelmagniﬁcations, and images were captured by an Olympus
DP25 camera (Olympus America) and Olympus CellSens
Dimension software version 1.11.Antibodies
The antibodies against p120ctn (number 610134; BD
Transduction Laboratories, San Jose, CA) and EGFR
(number 4267; Cell Signaling Technology, Beverly, MA)
were used for immunoblotting (p120ctn, 1:10,000; EGFR,
1:5000) and IHC (p120ctn, 1:200; EGFR, 1:75). Phos-
phorylated EGFR (Y1173) was also probed with a Cell
Signaling Technology antibody (1:5000) (number 4407;
Beverly, MA). Antibodies for keratin (KRT) 1 (1:200)
(ab11471), KRT4 (1:400) (ab51599), KRT5 (1:200)
(ab75869), KRT8 (1:400) (ab49778), and KRT10 (1:400)
(ab20208) were obtained from Abcam (Cambridge, MA).
KRT15 (1:300) antibody (number GTX61551) was pur-
chased from GeneTex, Inc. (Irvine, CA). The antibody for
Ki-67 (1:100; number M7240) was obtained from Dako
Cytomation. b-Actin (1:5000; number A5316), used as a
loading control for immunoblotting, was purchased from
Sigma-Aldrich Corp. (St. Louis, MO).Figure 2 In vitro characterization of EPC1 human esophageal kerati-
nocytes. A: Western blot analysis of EPC1-hTERT cells demonstrates down-
regulation of p120ctn in EPC1-P and EPC1-PE cells. Epidermal growth factorScoring and Morphological Analysis
All morphological and molecular analysis and scoring was
performed by an anatomical pathologist (X.Y.). A semi-
quantitative score system (H-score) was used in scoring
IHC.22 IHC immunoreactivity was graded as follows: 0 in-
dicates no staining; 1 indicates mild staining; 2 indicates
moderate staining; and 3 indicates strong staining. A
semiquantitative H-score was obtained by multiplying 3
percentage of strong staining, 2 percentage of moderate
staining, and 1 percentage of weak staining, giving a range
of 0 to 300. Normal-appearing adjacent epithelia were also
scored. Samples with a score <200 were classiﬁed as
negative (underexpression). Samples with a score >200
were classiﬁed as positive (overexpression).
Cellularity (number of nuclei in the epithelium) and
nuclear size of 3D culture sections were quantitated by digital
imaging of the H&E-stained sections. Five images of each
section at200magniﬁcation were taken. The cellularity and
nuclear size were analyzed by using ImageJ software version
1.46r (NIH, Bethesda, MD). Nuclear grade was scored on a 1
to 4 scale, measured by size, shape, chromatin, and nucleolus.
The proliferation index (Ki-67%) of 3D culture sections was
also measured by using ImageJ software.receptor (EGFR) is constitutively overexpressed in EPC1-E and EPC1-PE cells,
and activation of EGFR, as measured by phosphorylation at Y1173, is
increased in these cells. b-Actin is used as a loading control. B: In vitro
Boyden chamber migration assays were performed and demonstrate
signiﬁcantly increased migratory capabilities of EPC1-PE cells compared
with EPC1 control cells. C: In vitro invasion assays demonstrate a signiﬁ-
cantly increased ability of EPC1-PE cells to invade through Matrigel
compared with EPC1 control cells. B and C: Data are presented as
means  SEM. *P < 0.05, **P < 0.01, and ***P < 0.001.Statistical Analysis
A two-tailed Student’s t-test was used for determining sig-
niﬁcant differences between groups. The correlation of
p120ctn and EGFR expression was performed using c2
analysis. P  0.05 was considered statistically signiﬁcant.The American Journal of Pathology - ajp.amjpathol.orgResults
p120ctn Down-Regulation and EGFR Overexpression in
Human Esophageal Keratinocytes Result in Invasion
As mentioned previously, p120ctn down-regulation and
EGFR overexpression are each frequently occurring events
in ESCC and other cancers.8e15 IHC analysis was per-
formed on 10 human normal esophageal epithelia samples
with no evidence of dysplasia or tumor (Figure 1, AeC) and243
Lehman et al24 human ESCC samples containing histologically normal-
appearing adjacent (control) esophageal epithelia (control
epithelia not shown) (Figure 1, DeF, and Supplemental
Figure S1). We identiﬁed an inverse relationship between
p120ctn and EGFR, with decreased expression of p120ctn
in ESCC compared with control epithelium (Figure 1E and
Supplemental Figure S1, B, E, and H) and increased
expression of EGFR in ESCC compared with control
epithelium (Figure 1F and Supplemental Figure S1, C, F,
and I). In fact, p120ctn was down-regulated and EGFR was
overexpressed concurrently in 67% of human ESCC sam-
ples (Table 1), making this the most abundant condition in
our sample set. These data demonstrate that p120ctn down-
regulation, together with EGFR overexpression, is a con-
dition that is represented in most ESCCs analyzed; there-
fore, this study is focused on a signiﬁcant intersection
between two prominent genes in ESCC.
Western blot analyses show that parental EPC1-hTERT
cells exhibit high expression levels of p120ctn and low
levels of EGFR, making this cell line ideal to investigate the
role of these genes in ESCC. Therefore, we knocked down
p120ctn and overexpressed EGFR individually and in
combination in EPC1-hTERT cells. The p120ctn knock-
down was performed using an inducible lentiviral p120ctn
shRNA in EPC1-hTERT cells, whereas EGFR over-
expression was achieved by transducing cells with an EGFRFigure 3 p120ctn and epidermal growth factor receptor (EGFR) expression in
staining of 3D organotypic cultures with EPC1-hTERT control cells demonstrates an
3D culture (B) and disorganization and increased epithelial thickness occurs with
phenotype. Insets (AeD): epithelial morphological features at a higher magniﬁc
p120ctn in EPC1-hTERT controls (E) and EPC1-E cultures (G). Expression of p120ctn
the loss of p120ctn expression in the most invasive cells. IHC staining of 3D cultur
EPC1-P cultures (J), but increased expression of EGFR in EPC1-E (K) and EPC1-PE
cells. Scale bar Z 50 mm.
244del (E746-A750) mutant. This mutant form of EGFR was
used to mimic the levels of EGFR activation seen in human
ESCC. Western blot analysis shows that p120ctn was suc-
cessfully down-regulated in EPC1-P cells and EGFR was
overexpressed in EPC1-E cells (Figure 2A). We were also
able to establish EPC1-PE cells, which exhibit both
decreased p120ctn and increased EGFR (Figure 2A).
Importantly, activated EGFR levels were increased in both
EPC1-E and EPC1-PE cells, as measured by phosphoryla-
tion of EGFR at tyrosine 1173 (Figure 2A).
The in vitro migratory and invasive capabilities of
EPC1-PE cells were then assessed using Boyden chamber
migration assays and Matrigel invasion assays, respec-
tively. Results of these experiments demonstrated a
signiﬁcantly increased ability of EPC1-PE cells to migrate
compared with EPC1-hTERT control (P< 0.001), EPC1-P
(P < 0.001), or EPC1-E cells (P < 0.01) (Figure 2B).
Moreover, the invasive capabilities of the EPC1-PE cells
were signiﬁcantly increased in comparison to EPC1-
hTERT control cells (P < 0.01) and EPC1-P (P < 0.05)
or EPC1-E cells (P< 0.05) (Figure 2C). These experiments
were performed using EPC2-hTERT cells and yielded
identical results. These data suggest that the effects seen as
a result of p120ctn down-regulation and EGFR over-
expression together are greater than p120ctn or EGFR
modiﬁcation alone.a 3D culture model system using activated esophageal ﬁbroblasts. A: H&E
organized epithelial layer. Mild disorganization occurs with EPC1-P cells in
EPC1-E cells (C). D: EPC1-PE cells in 3D culture result in a highly invasive
ation. IHC staining of 3D cultures for p120ctn displays wild-type levels of
is decreased in EPC1-P (F) and EPC1-PE 3D cultures (H). Arrow in H denotes
es for EGFR displays wild-type levels of EGFR in EPC1-hTERT controls (I) and
cultures (L). Arrow in L denotes EGFR overexpression in the most invasive
ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Morphological analysis of 3D cultures. A: Cellularity is
signiﬁcantly increased in EPC1-PE human esophageal keratinocyte 3D cul-
tures. B: Nuclear size is signiﬁcantly increased in EPC1-PE cultures
compared with the control. C: Nuclear grades of EPC1-hTERT control and
EPC1-P 3D cultures were considered to be grade 1, whereas EPC1-E cultures
were grades 2 and 3, and EPC1-PE cultures were grades 3 and 4. D: Ki-67
staining demonstrates a signiﬁcant increase in the percentage of prolif-
erating cells in EPC1-PE cultures compared with EPC1-hTERT control and
EPC1-E cultures. A, B, and D: Data are presented as means  SEM.
*P < 0.05, **P < 0.01, and ***P < 0.001.
Figure 5 Characterization of 3D culture model system with human adult
esophageal ﬁbroblasts. A: H&E staining of 3D cultures with HEF and EPC1-
hTERT cells demonstrates an organized epithelial layer. B: Mild disorgani-
zation occurs with EPC1-P cells in 3D culture. C: Cultures with EPC1-E cells
display epithelial disorganization and the formation of keratin pearls.
D: Cultures seeded with EPC1-PE cells that have down-regulated p120ctn
and overexpression of epidermal growth factor receptor display an invasive
phenotype. Insets: Epithelial morphological features at a higher magniﬁ-
cation. Scale bar Z 50 mm.
p120ctn and EGFR Mimic ESCC in 3D Modelp120ctn Down-Regulation and EGFR Overexpression
Result in an Invasive Phenotype in a 3D Culture Model
System That Is Independent of Fibroblast Activation
Given the increased invasive capabilities of EPC1-PE cells,
we wanted to further study these esophageal keratinocytes
in a more biologically relevant 3D model of ESCC. Our 3D
model of the stratiﬁed squamous esophageal epitheliumThe American Journal of Pathology - ajp.amjpathol.orgincorporates the interaction between genetically modiﬁed
epithelial cells and ﬁbroblasts that exist in the stromal
compartment, because this interaction is vital for cancer cell
invasion.20,21 Herein, activated ﬁbroblasts (FEF3) were
embedded within the matrix beneath EPC1-hTERT cells.
H&E staining of 3D cultures with EPC1-hTERT control
cells showed an organized epithelium (Figure 3A), whereas
mild disorganization of the basal layer was seen in EPC1-P
cell cultures (Figure 3B). EPC1-E cultures showed moder-
ate disorganization with increased epithelial thickness
(Figure 3C). Interestingly, only in EPC1-PE cultures did the
epithelium appear to be transformed, resulting in cellular
invasion into the matrix (Figure 3D). IHC staining was
performed to examine the expression of p120ctn and EGFR
in 3D cultures. Down-regulation of p120ctn was seen in
most EPC1-P (Figure 3F) and EPC1-PE cells (Figure 3H) in
3D culture, with strong knockdown in approximately 50%
of cells, compared with EPC1-hTERT control cells
(Figure 3E) and EPC1-E cells (Figure 3G) in 3D culture.
Interestingly, there was nearly complete loss of p120ctn in
the most invasive components of the EPC1-PE cultures
(Figure 3H). IHC also demonstrated overexpression of
EGFR in EPC1-E (Figure 3K) and EPC1-PE cultures
(Figure 3L) compared with the EPC1-hTERT control
(Figure 3I) and EPC1-P cultures (Figure 3J).
Morphological features were assessed in 3D culture sam-
ples as a measure of similarity between the EPC1-PE cells in
3D culture and human ESCC. Cellularity was signiﬁcantly
increased in EPC1-PE cultures compared with the EPC1-
hTERT control (P < 0.001), EPC1-P (P < 0.001), and
EPC1-E cultures (P < 0.05) (Figure 4A). Measurements of
nuclear size demonstrated a signiﬁcant increase in the nuclear245
Figure 6 Keratin expression proﬁles of esophageal squamous cell carci-
noma (ESCC) human samples. A: IHC staining of ESCC tumor excisions dem-
onstrates that KRT1 expression does not change in ESCC. B: Expression of KRT4
is lost in ESCC compared with control epithelium. C: KRT5 expression does not
change in ESCC. D: Control esophageal epithelium is negative for KRT8
staining, but focal and weak expression is gained in ESCC. KRT10 expression is
decreased in ESCC (E), as is KRT15 (F), compared with expression levels in
control epithelium. Arrowhead denotes normal-appearing adjacent epithe-
lium (control epithelium); asterisk, ESCC. Scale barZ 100 mm.
Lehman et alsize of EPC1-PE cells in 3D culture compared with EPC1-
hTERT control cells in culture (P < 0.01) (Figure 4B). With
nuclear grade scored on a 1 to 4 scale, EPC1-hTERT control
and EPC1-P cultures had a nuclear grade of 1, whereas EPC1-
E cultures were grades 2 to 3 (Figure 4C). EPC1-PE cultures
were grades 3 to 4, similar to ESCC, which typically has a
nuclear grade of 323 (Figure 4C). Proliferation was then
measured in 3D cultures by Ki-67 staining. The percentage of
proliferating cells was signiﬁcantly increased in EPC1-PE
cultures compared with EPC1-hTERT control (P < 0.001)
and EPC1-E cultures (P< 0.01) (Figure 4D). The results of the
morphological analysis of 3D cultures showed that the
morphological characteristics of our 3D model when p120ctn
is down-regulated and EGFR is overexpressed resembled
those of human ESCC.23,24
In agreement with the 3D culture studies described above,
previous work reported that the source and activity levels of
ﬁbroblasts in the 3D culture model are critical in affecting
the extent of tumor cell invasion and degree of tumor dif-
ferentiation.20 Because our original experiments used FEF3
ﬁbroblasts as a model of a reactive stromal component, we
next investigated the extent to which altered p120ctn and
EGFR expression cooperated with a normal stromal
component incorporated into the matrix of our 3D system.
For this, we used quiescent ﬁbroblasts (HEFs). Histological
assessment of the 3D cultures showed that EPC1-hTERT
control cells formed an organized epithelium on top of the
HEF-containing matrix (Figure 5A), whereas mild disorga-
nization of the basal layer was seen in EPC1-P cultures
(Figure 5B). EPC1-E cultures showed disorganization,
increased epithelial thickness, and the formation of keratin
pearls in the epithelium, but contained no invasion
(Figure 5C). As seen in cultures with activated ﬁbroblasts,
only in EPC1-PE cultures did invasion into the quiescent
HEF-containing extracellular matrix occur (Figure 5D).
Activation of the quiescent HEFs was tested as a possible
explanation for the apparent ﬁbroblast-independent invasion
of the EPC1-PE cells. Immunoﬂuorescence was performed
on HEF 3D cultures to examine a-smooth muscle actin, a
common marker of ﬁbroblast activation. a-Smooth muscle
actin staining was negative in all HEF 3D cultures (data not
shown). These data suggest that in the 3D culture system,
p120ctn down-regulation and EGFR overexpression result
in increased aggressive behavior of squamous epithelium in
a relatively cell-autonomous manner and are not dependent
on ﬁbroblast activation state in this culture system.
Keratin Expression Patterns of EPC1-PE 3D Cultures
Show a High Level of Similarity to Human ESCC
IHC for keratins is used extensively as diagnostic tumor
markers and prognostic markers, because the expression of
speciﬁc keratins may correlate with epithelial differentiation
states.25e27 Six keratins commonly used as molecular
markers were selected for IHC analysis of ESCC and 3D
culture samples, including KRT1, KRT4, KRT5, KRT8,246KRT10, and KRT15.25,28,29 These keratins have been
characterized as having differential expression patterns in
squamous cell carcinomas, although less is known about
KRT15. Speciﬁcally, KRT5 and KRT8 are both typically
expressed in squamous cell carcinomas, particularly poorly
differentiated cases.27,29 Likewise, KRT1 and KRT10 have
differential expression in poorly differentiated squamous
cell carcinomas, often with decreased and/or focal expres-
sion.27,29 Keratin 4 is used as a marker of squamous
cell carcinoma and is frequently lost in ESCC compared
with normal esophageal epithelia, indicative of malignant
transformation.30e32 Although there is little known about
the differential expression of KRT15 in tumors and, thus, its
use as a diagnostic marker, a recent study demonstrated that
KRT15 was generally down-regulated in moderately or
poorly differentiated oral squamous cell carcinoma.27,33
IHC analysis was performed on human ESCC contain-
ing histologically normal-appearing adjacent (control)
esophageal epithelia (Figure 6) and normal esophageal
epithelia with no evidence of dysplasia or tumor (data not
shown) to further assess the relevance of the 3D system to
human ESCC. Expression levels of keratins were evaluated
in human samples, with KRT1 (Figure 6A) showing pos-
itive staining with no change in expression between controlajp.amjpathol.org - The American Journal of Pathology
Figure 7 Keratin expression proﬁles of EPC1 3D cultures with activated fetal esophageal ﬁbroblasts. IHC staining of 3D cultures demonstrates no change in
staining for KRT1 (AeD), KRT5 (IeL), or KRT8 (MeP) between any conditions. EPC1-PE cultures have decreased expression levels of KRT4 (EeH) and KRT10
(QeT) and loss of KRT15 (UeX), compared with EPC1-hTERT control 3D cultures. Scale bar Z 50 mm.
p120ctn and EGFR Mimic ESCC in 3D Modelepithelium and ESCC. Keratin 4 expression was lost in
ESCC (Figure 6B), whereas KRT5 (Figure 6C) staining
was positive with no change in expression between control
epithelium and ESCC. Keratin 8 expression was gained in
ESCC with weak staining (Figure 6D). Expression of
KRT10 (Figure 6E) and KRT15 (Figure 6F) was decreased
in ESCC compared with control epithelium.
Keratin expression proﬁles in EPC1-PE 3D cultures were
nearly identical to those seen in ESCC human samples. IHCThe American Journal of Pathology - ajp.amjpathol.orgof 3D cultures with activated fetal esophageal ﬁbroblasts
revealed that KRT1 was expressed in all 3D cultures and
expression levels did not change between EPC1-hTERT
control, EPC1-P, EPC1-E, and EPC1-PE cultures (Figure 7,
AeD). The same was seen for KRT5, with no change in
expression between EPC1-hTERT control, EPC1-P,
EPC1-E, and EPC1-PE cultures (Figure 7, IeL). IHC of
KRT8 showed no staining in 3D cultures (Figure 7, MeP).
Keratin 4 was decreased in expression in EPC1-PE 3D247
Figure 8 Keratin expression proﬁles of EPC1 3D cultures with quiescent adult human esophageal ﬁbroblasts. IHC staining of 3D cultures demonstrates
decreased expression of KRT10 in EPC1-PE cultures (D) compared with EPC1-hTERT controls (A), EPC1-P (B), or EPC1-E (C) cells in 3D culture. Expression of
KRT15 is decreased in EPC1-PE 3D cultures (H) compared with EPC1-hTERT controls (E), EPC1-P (F), or EPC1-E (G) cells in 3D culture. Scale bar Z 50 mm.
Table 2 Keratin Expression Proﬁles of EPC1-PE Cells in 3D
Culture Are Nearly Identical to Human ESCC
Variable K1 K4 K5 K8 K10 K15
Normal epithelium þ þ þ  þ þ
Control þ þ þ  þ þ
ESCC þ  þ þ  
EPC1-PE þ  þ   
þ, present; e, absent.
Lehman et alcultures compared with EPC1-hTERT control, EPC1-P, and
EPC1-E 3D cultures (Figure 7, EeH). Likewise, KRT10
was decreased in expression in EPC1-PE 3D cultures
compared with EPC1-hTERT control, EPC1-P, and EPC1-E
3D cultures (Figure 7, QeT). Finally, expression of KRT15
was found to be decreased in EPC1-PE 3D cultures
compared with all other conditions (Figure 7, UeX).
IHC was also performed on 3D cultures with quiescent
human esophageal ﬁbroblasts to determine whether
expression of keratins changed with a different stromal
source. Expression of KRT10 and KRT15 was examined,
both of which were decreased in expression in ESCC
samples and EPC1-PE cells grown on FEF3 3D cultures.
Results demonstrated that in comparison to EPC1-hTERT
control cultures (Figure 8A), EPC1-P cultures (Figure 8B),
and EPC1-E cultures (Figure 8C), KRT10 decreased in
expression in EPC1-PE cells in 3D culture with quiescent
ﬁbroblasts (Figure 8D). Likewise, KRT15 expression was
decreased in EPC1-PE cultures compared with the EPC1-
hTERT, EPC1-P, or EPC1-E cells in 3D culture with
quiescent ﬁbroblasts (Figure 8, EeH). These data demon-
strate that the expression patterns of KRT10 and KRT15 in
EPC1-PE cells in 3D culture with HEFs are identical to
those of both FEF3 3D cultures and human ESCC.
Together, the results of IHC analysis of keratin expres-
sion in our 3D culture model system and human ESCC
showed that EPC1-hTERT control cells in 3D culture mimic
control epithelium and EPC1-PE cells are able to recapitu-
late human ESCC in a relevant 3D culture model (Table 2).
p120ctn and EGFR Cooperate to Affect E-Cadherin
Expression
E-cadherin is classically known to be a component of the
adherens junction complex and is associated with the
epithelial-to-mesenchymal transition (EMT). Interestingly,
p120ctn interacts with and stabilizes E-cadherin in the248adherens junction complex,34e36 and it has been demon-
strated previously that loss or down-regulation of p120ctn
correlates with E-cadherin levels in ESCC tumors.11,12
Because our data have established that p120ctn down-
regulation and EGFR overexpression induce an invasive
phenotype in ESCC, we investigated if alterations in
E-cadherin expression could be implicated. Western blot
analysis demonstrated that in EPC1-P cells, E-cadherin
expression levels were decreased compared with parental
cells (Figure 9). Interestingly, in EPC1-PE cells, E-cadherin
expression levels were decreased to an even greater degree
(5.6-fold compared with EPC1-P cells) (Figure 9), indi-
cating additional suppression of E-cadherin in the context of
both p120ctn down-regulation and EGFR overexpression.
These results directly implicate changes in p120ctn and
EGFR expression in the regulation of E-cadherin
expression.Discussion
Like many malignancies, ESCC develops as a result of
multiple genetic alterations. The role of p120ctn as a tumor
suppressor in ESCC has been ﬁrmly established through
previous studies, including the development of a conditional
p120ctn knockout mouse model.12 However, p120ctn loss
almost certainly coincides with additional genetic event(s)ajp.amjpathol.org - The American Journal of Pathology
Figure 9 E-cadherin expression in EPC1-hTERT cells. Western blot
analysis demonstrates a decrease in E-cadherin protein levels when p120ctn
is down-regulated in EPC1-P cells and a further decrease in E-cadherin
expression in EPC1-PE cells. b-Actin is used as a loading control. Band
intensity was quantiﬁed by densitometry and normalized to EPC1-hTERT b-
actin. Values are expressed as relative to the EPC1-hTERT control.
p120ctn and EGFR Mimic ESCC in 3D Modelin humans, resulting in the development of ESCC. EGFR
overexpression is associated with early events in tumor
initiation, including squamous dysplasia.37,38 Such as
p120ctn, there exists evidence for a role of EGFR in ESCC.
Yet, the potential synergistic relationship between this
tumor suppressor and oncogene has not been explored.
We have established p120ctn down-regulation and EGFR
overexpression as a common condition in ESCC, reinforc-
ing the relevance and translation of these genes and the 3D
model to the human disease. Herein, we demonstrated the
development of an invasive ESCC phenotype when p120ctn
is down-regulated in the context of EGFR overexpression,
but not when either event occurs independently. In the 3D
tissue culture model system, this aggressive phenotype
persisted regardless of ﬁbroblast activation status. This is
contrary to previously published work demonstrating the
key dependence of ESCC invasion on ﬁbroblast origin.20
These studies examined EGFR, hTERT, and p53 alter-
ations in the epithelium, and these cells may indeed need to
interact with the stroma in a more prevalent way to induce
tumor invasion. Because the EPC1-PE cells invade without
this dependence on ﬁbroblast activation state, we may be
studying a more aggressive epithelial phenotype than has
been previously examined,20 although further studies are
required. Nonetheless, our data suggest the possibility that
p120ctn down-regulation and EGFR overexpression act in
an epithelial cell-autonomous manner to drive invasion. The
prognosis for patients with ESCC is known to be poor
because of the high rate of local invasion and distant me-
tastases at the time of diagnosis. p120ctn down-regulation in
squamous cell carcinomas has been correlated with poor
patient prognosis,11,39,40 as has EGFR overexpression in
ESCC.41,42 Our study demonstrates that the cooperation of
p120ctn down-regulation and EGFR overexpression leads to
an even more aggressive phenotype than either alteration
alone, which may negatively affect the prognosis of ESCC
patients even further. Therefore, these genes may have
future prognostic and therapeutic value.The American Journal of Pathology - ajp.amjpathol.orgThe ability of the 3D model of ESCC to lead to an
invasive phenotype provides a tool with which to study the
biological characteristics behind ESCC invasion. Our 3D
model morphologically resembles human ESCC develop-
ment, including increased cellularity and proliferation,
dysplastic changes, and stromal invasion. Indeed, the
development and progression of ESCC is multifactorial, and
we are taking into account only two genetic events; how-
ever, on the basis of morphological and molecular analyses,
we are able to mimic human disease. This 3D culture system
is a relevant model of ESCC in which we can manipulate
the epithelium, allowing us to further investigate the events
that affect ESCC invasion. Moreover, once validated using
conventional therapeutics, our 3D model has future potential
use in testing novel therapeutics in a preclinical setting.
Keratins play important roles in a diverse array of cellular
functions.25,27 These data suggest that keratin expression
patterns may be related to progressive development of
ESCC, and more recent studies even implicate keratin
involvement in cancer cell invasion and metastasis.43e46
Keratin expression patterns are typically cell type, differ-
entiation, and functional status dependent in epithelial
cells.25 Epithelial tumors, including ESCC, largely maintain
the features of speciﬁc keratin expression associated with
the cell type of origin,25 although tumors may deviate from
the patterns of their normal origin by gaining or losing
keratins.26,27,29,47,48 Our data suggest speciﬁc keratin
expression patterns in ESCC, with our 3D culture model
displaying loss of some keratins in the most invasive EPC1-
PE cells in culture. Further studies with the use of our 3D
culture system are required to understand the possible role
keratins may be playing in the invasive phenotype of ESCC,
particularly in the context of p120ctn down-regulation and
EGFR overexpression.
Our studies have demonstrated that p120ctn down-
regulation and EGFR overexpression lead to an aggressive
and invasive phenotype in ESCC. However, the mecha-
nisms involved in the synergistic relationship between
p120ctn down-regulation and EGFR overexpression that
leads to ESCC invasion remain unknown. We have shown
that E-cadherin levels are decreased with p120ctn down-
regulation and even more so when EGFR is concurrently
overexpressed. Loss of cell adhesion is vital in cellular
migration and invasion and, therefore, E-cadherin may be
playing a role in the cooperation between p120ctn and
EGFR. E-cadherin is known to be associated with the EMT,
and this may be a mechanism by which E-cadherin is
involved in the invasive phenotype in our culture system.
Further study of the EMT and commonly associated tran-
scription factors involved in the process would be inter-
esting in the context of p120ctn down-regulation and EGFR
overexpression. Nonetheless, the interaction of pathways
downstream of p120ctn down-regulation and EGFR over-
expression has yet to be investigated, and we believe will be
key in discovering the mechanisms behind how p120ctn and
EGFR lead to an aggressive phenotype in ESCC.249
Lehman et alThe relationship between p120ctn down-regulation and
EGFR overexpression that induces an invasive phenotype
will aid us in developing more effective therapeutic drugs
for ESCC patients but will also be applicable to many
cancer types. Down-regulation or loss of p120ctn has been
demonstrated in 11 other cancer types in addition to ESCC,
including colon, breast, prostate, and lung.8,9,11,12,39,40,49e53
Likewise, EGFR overexpression has been indicated in these
and many other cancers, including melanoma and
bladder.54e58 Given the prominence of p120ctn and EGFR
in these diseases, it is likely that the intersection of these two
genes will be important in not only ESCC, but other cancer
types as well. Therefore, our studies to investigate the
cooperation between p120ctn down-regulation and EGFR
overexpression, with the use of our 3D culture model sys-
tem, will potentially provide insight into the biological
features of invasion in a wide spectrum of diseases.
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